Clinical Trials on 再発肝細胞がん in Hong Kong
合計727件
-
Humanity & Health Medical Group Limited募集
-
Humanity & Health Medical Group LimitedBeijing 302 Hospital; Kindai University Faculty of Medicine終了しました
-
The University of Hong KongMerck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany完了
-
The University of Hong Kong完了
-
Aegera TherapeuticsChinese University of Hong Kong完了
-
The University of Hong Kongわからない
-
Bio-Cancer Treatment International LimitedThe University of Hong Kong完了
-
Chinese University of Hong KongHealth and Medicine Research Fund募集
-
Chinese University of Hong KongThe Hong Kong Society of Gastroenterology完了
-
Bio-Cancer Treatment International LimitedThe University of Hong Kong; Chinese University of Hong Kong完了
-
Bio-Cancer Treatment International LimitedThe University of Hong Kong; Chinese University of Hong Kong完了
-
Bio-Cancer Treatment International LimitedThe University of Hong Kong; Chinese University of Hong Kong完了
-
Chinese University of Hong Kong完了
-
Chinese University of Hong KongPrince of Wales Hospital, Shatin, Hong Kong完了
-
The University of Hong Kongわからない
-
Zai Lab (Shanghai) Co., Ltd.終了しました
-
Chinese University of Hong Kong募集
-
Chinese University of Hong Kongまだ募集していません
-
Chinese University of Hong Kong積極的、募集していないEUSガイド付きシアノアクリレート注入 | 内視鏡下静脈瘤結紮術 | 肝細胞がん | 食道静脈瘤出血香港
-
Chinese University of Hong KongPrince of Wales Hospital, Shatin, Hong Kong終了しました
-
SCG Cell Therapy Pte. Ltd.募集
-
The University of Hong Kong募集再発膠芽腫 | 再発神経膠腫 | ポリ ADP リボース ポリメラーゼ (PARP) 阻害剤 | PTEN 遺伝子の不活化 | IDH突然変異香港
-
Hospital Authority, Hong KongSchering-Ploughわからない